GLP-1 treatment can attenuate abnormal autophagy induced by ROS and inflammation through upregulating HDAC6 via the GLP-1R-ERK1/2 pathway [150]
GRF (1-29) itself was found to suffer from rapid metabolic clearance, leading to the synthesis of analogues with substituted amino acids more resistant to enzymatic cleavage
Excessive Sugar Intake High sugar intake can lead to a process called glycation
Additional trials and studies are expected to be opened to patients over the next several months
These broader metabolic benefits are part of the reason researchers consider tripleagonist therapies multitarget obesity and metabolicdisease treatments rather than simple appetite suppressants. How Medically Supervised Programs May Use Retatrutide in the Future If ongoing trials continue to show strong benefits with acceptable safety, and if retatrutide eventually receives FDA approval, it is likely to become one more option in the toolbox for medically supervised weightloss programs rather than a standalone miracle drug. A careful, supervised approach would typically include: Comprehensive evaluation before prescribing Detailed medical history, including prior responses to GLP1 or dualagonist medications
Their common side effects include nausea, diarrhea, and constipation, although they tend to be mild to moderate when you use them properly and improve as your body gets used to the medication